Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

NCT07651319 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Dementia (AD)

Interventions

DRUG: IL-2 (Aldesleukin)
DRUG: Semaglutide Plus IL-2
DRUG: Placebo

Sponsor

The Methodist Hospital Research Institute